Combination azilsartan medoxomil and chlorthalidone was shown to be superior to combination olmesartan medoxomil and hydrochlorothiazide in lowering BP, according to data published in Hypertension.

Of 52 subjects screened, 24 normotensive individuals (mean systolic and diastolic BPs 129.4 ± 7.5 and 75.2 ± 6.0mm Hg, respectively) were enrolled in the study and randomised to treatment. Of these, ...

May 24, 2011 (New York, New York) — The use of the combination therapy azilsartan medoxomil (Edarbi, Takeda Pharmaceuticals) and chlorthalidone resulted in a more effective reduction in systolic blood ...

Olmesartan medoxomil, hydrochlorothiazide; 20mg/12.5mg, 40mg/12.5mg, 40mg/25mg; tabs. Olmesartan blocks the vasoconstrictor effects of angiotensin II by selectively blocking the binding of angiotensin ...

Parsippany, NJ (May 26, 2004) – New data from two different clinical studies demonstrated that patients with hypertension can achieve more aggressive blood pressure goal rates using antihypertensive ...

A prespecified subgroup analysis of a 44-week open-label extension study is presented. The efficacy and safety of the combination of amlodipine (AML)+ olmesartan medoxomil (OM), with and without the ...

Parsippany, NJ (May 27, 2005) – Data from two clinical studies presented at the American Society of Hypertension's Twentieth Annual Scientific Meeting (ASH 2005) in San Francisco demonstrated that ...

Investigators found azilsartan medoxomil plus chlorthalidone to be more effective for reducing systolic blood pressure (SBP) than olmesartan plus hydrochlorothiazide (HCTZ). Both combinations include ...

The therapeutic profile of olmesartan medoxomil, which is a recently developed angiotensin II (A II) receptor blocker, has been compared with four commonly used antihypertensive therapeutic drugs ...

NEW YORK—An investigational triple regimen of olmesartan medoxomil (OM), amlodipine besylate (AML), and hydrochlorothiazide (HCTZ) may result in significantly greater mean reductions in BP compared ...

NEW YORK—Long-term data show that a three-drug combination is safe and effective for treating hypertension in elderly patients, according to a report at the American Society of Hypertension annual ...

Deerfield, Ill., February 6, 2012 and Osaka, Japan, February 7, 2012 - Takeda Pharmaceutical Company Limited (Takeda) and its wholly-owned subsidiary, Takeda ...